Land: Storbritannien
Språk: engelska
Källa: VMD (Veterinary Medicines Directorate)
Carprofen
Ecuphar NV
QM01AE91
Carprofen
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Anti Inflammatory NSAID
Expired
2012-05-09
Revised: February 2017 AN: 00603/2016 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Acticarp 50 mg/ml Solution for Injection for Cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per ml: ACTIVE SUBSTANCE: Carprofen 50 mg EXCIPIENTS: Ethanol anhydrous 0.1 ml For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, pale straw yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product is indicated as an adjunct to antimicrobial therapy to reduce clinical signs in acute infectious respiratory disease and acute mastitis in cattle. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in animals suffering from cardiac, hepatic or renal impairment. Do not use in animals suffering from gastro-intestinal ulceration or bleeding. Do not use where there is evidence of a blood dyscrasia. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Revised: February 2017 AN: 00603/2016 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity. Concurrent administration of potentially nephrotoxic drugs should be avoided. Do not exceed the stated dose or the duration of treatment. Do not administer other NSAID’s concurrently or within 24 hours of each other. As NSAID therapy can be accompanied by GI or renal impairment, adjunctive fluid therapy should be considered especially in the case of acute mastitis treatment. Special precautions to be taken by the person administering the veterinary medicinal product to animals Carprofen, in common with other NSAIDs, has been shown to exhibit photosensitising potential in laboratory studies. Avoid contact with skin and eyes. Should this occur, wash the affected areas immediately. Seek medical attention if irritation Läs hela dokumentet